INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹221 Cr | ₹221 Cr | ₹371 Cr | ₹334 Cr | ₹315 Cr |
What is the latest Total Current Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹221 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹371 Cr |
| Mar2022 | ₹334 Cr |
| Mar2021 | ₹315 Cr |
How is Total Current Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹221 Cr | -0.31 | |
| Mar2024 | ₹221 Cr | -40.37 | |
| Mar2023 | ₹371 Cr | 10.95 | |
| Mar2022 | ₹334 Cr | 6.34 | |
| Mar2021 | ₹315 Cr | - | |
Compare Total Current Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹974.7 Cr | 5.4% | 33.2% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 5.4% |
33.2% |
4.4% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses